- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/037 - Peptides having up to four amino acids in a fully defined sequenceDerivatives thereof containing at least one abnormal peptide link the abnormal link being formed by the side chain of an alpha-amino acid, e.g. gamma-Glu, epsilon-Lys, glutathione
Patent holdings for IPC class C07K 5/037
Total number of patents in this class: 96
10-year publication summary
3
|
9
|
4
|
9
|
4
|
8
|
4
|
6
|
3
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Kyowa Hakko Bio Co., Ltd. | 304 |
13 |
Apotex Technologies Inc. | 16 |
7 |
Kaneka Corporation | 4501 |
3 |
Centre National de La Recherche Scientifique | 10165 |
2 |
Ajinomoto Co., Inc. | 2305 |
2 |
Provincial Health Services Authority | 179 |
2 |
The University of British Columbia | 1475 |
2 |
The University of Queensland | 655 |
2 |
Fusion Pharmaceuticals Inc. | 85 |
2 |
Obschestvo S Ogranichennoi Otvetstvennostiyu "z Therapeutics" | 3 |
2 |
Next Level Health Sciences Inc. | 14 |
2 |
The Regents of the University of California | 19661 |
1 |
Janssen Pharmaceutica N.V. | 3437 |
1 |
Bayer Pharma AG | 1058 |
1 |
The Johns Hopkins University | 5568 |
1 |
Novozymes A/S | 3296 |
1 |
Purdue Research Foundation | 3523 |
1 |
Northwestern University | 3307 |
1 |
Beijing Molecule Science and Technology Co., Ltd. | 12 |
1 |
Beijing Normal University | 91 |
1 |
Other owners | 48 |